http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2008016546-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61cdc68206eff9d158a7c0a95c471cfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a701038506bfc54333cbae0ff07949 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0447ca2e67e2c48c163b3bae4f00ea04 |
| publicationDate | 2009-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2008016546-A |
| titleOfInvention | PREPARATION AND APPLICATION IN THERAPEUTICS OF IMIDAZO DERIVATIVES [1,2-A] PIRIDINA-2-CARBOXAMIDAS. |
| abstract | The invention relates to imidazopyridine-2-carboxamide derivatives, of general formula (I), X represents one of the following groups: an optionally substituted phenyl group: R1 represents a hydrogen atom, a halogen atom, an alkoxy group ( from 1 to 6 carbon atoms), an alkyl group (from 1 to 6 carbon atoms), a cycloalkyl group (from 3 to 7 carbon atoms) -alkyl (from 1 to 6 carbon atoms), a cycloalkyl group ( from 3 to 7 carbon atoms) -alkoxy (from 1 to 6 carbon atoms), an amino group, an NRcRd group; the alkyl and alkoxy groups may optionally be substituted; R2 represents one of the following groups; a hydrogen atom, an optionally substituted alkyl (1 to 6 carbon atoms) group, an optionally substituted alkoxy (1 to 6 carbon atoms) group, a cycloalkyl (3 to 7 carbon atoms) -alkyl group ( from 1 to 6 carbon atoms), a cycloalkyl group (from 3 to 7 carbon atoms) -alkoxy (from 1 to 6 carbon atoms); an alkylene group (from 2 to 6 carbon atoms), an alkynyl group (from 2 to 6 carbon atoms), a group -CO-R5-, a group -CO-NR6R7, a group -CO-O- R8- , a group -NR9-CO-R10, a group -NR11R12, a halogen atom, a cyano group; an optionally substituted phenyl group; R3 represents a hydrogen atom, an alkyl group (from 1 to 6 carbon atoms), an alkoxy group (from 1 to 6 carbon atoms) or a halogen atom, R4 represents a hydrogen atom, an alkyl group (from 1 to 4 carbon atoms), an alkoxy group (from 1 to 4 carbon atoms) or a fluorine atom. Procedure of preparation and application in therapeutics. |
| priorityDate | 2006-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 279.